Literature DB >> 1317524

Endotoxin transfer through dialysis membranes: small- versus large-pore membranes.

R Vanholder1, E Van Haecke, N Veys, S Ringoir.   

Abstract

In this in-vivo study, dialysate and serum endotoxin was evaluated before and after haemodialysis with small-pore (PS400) and large-pore (PS600) polysulphone dialysers, and before and after haemodiafiltration with the PS600 filter. The source of the endotoxin was the presence in dialysate of Pseudomonads at a concentration of 10(3)-10(4) CFU/ml. Endotoxin was measured by a modified chromogenic limulus amoebocyte lysate (LAL) assay. In spite of dialysate endotoxin concentrations greater than 100 pg/ml, no changes in pre- versus posttreatment LAL reactivity were observed in PS400 dialysis and PS600 haemodiafiltration. In contrast, PS600 haemodialysis was related to an increase in serum LAL reactivity from 1.3 +/- 1.5 to 3.8 +/- 2.0 pg/ml (n = 15, P less than 0.01), and five patients (33.3%) showed a post-dialysis value in excess of 5 pg/ml. Our data are consistent with the absence of in-vivo endotoxin transfer during haemodialysis with small-pore dialyser membranes, and during haemodiafiltration with membranes with larger pores. An increase in LAL reactivity during haemodialysis with membranes with larger pores is, however, present, presumably due to the occurrence of backdiffusion/filtration with that specific strategy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317524     DOI: 10.1093/oxfordjournals.ndt.a092138

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

Review 1.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

2.  Clinical and microbiological effects of dialyzers reuse in hemodialysis patients.

Authors:  Isabella Carvalho Ribeiro; Noemí Angelica Vieira Roza; Diego Andreazzi Duarte; Dioze Guadagnini; Rosilene Motta Elias; Rodrigo Bueno de Oliveira
Journal:  J Bras Nefrol       Date:  2019-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.